CUSIP 75943R102 · who reports it, how much, and how much it matters to them
31 of the 720 hedge fund managers we track reported shares of Relay Therapeutics, Inc. (Nasdaq: RLAY) on Form 13F for 30 June 2026. Between them they reported USD 870m. The largest position belongs to Casdin Capital, at USD 300m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Casdin Capital3 funds on PPLI.com | USD 300m | 15.0% |
| 2 | Perceptive Advisors6 funds on PPLI.com | USD 264m | 4.0% |
| 3 | Kynam Capital Management1 fund on PPLI.com | USD 62m | 3.4% |
| 4 | Baker Bros. Advisors2 funds on PPLI.com | USD 53m | 0.3% |
| 5 | Polar Capital LLP26 funds on PPLI.com | USD 33m | 0.1% |
| 6 | Adage Capital Management1 fund on PPLI.com | USD 33m | 0.0% |
| 7 | Two Sigma Investments35 funds on PPLI.com | USD 13m | 0.0% |
| 8 | ECOR1 Capital3 funds on PPLI.com | USD 13m | 0.6% |
| 9 | Millennium Management6 funds on PPLI.com | USD 11m | 0.0% |
| 10 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 10m | 0.4% |
| 11 | HighVista Strategies27 funds on PPLI.com | USD 9.5m | 2.2% |
| 12 | Citadel Advisors32 funds on PPLI.com | USD 8.9m | 0.0% |
| 13 | Boxer Capital Management1 fund on PPLI.com | USD 8.4m | 0.6% |
| 14 | Eversept Partners3 funds on PPLI.com | USD 8.1m | 0.4% |
| 15 | Moore Capital Management7 funds on PPLI.com | USD 7.7m | 0.1% |
| 16 | Logos Global Management1 fund on PPLI.com | USD 6.5m | 0.3% |
| 17 | Sphera Funds Management1 fund on PPLI.com | USD 4.4m | 0.6% |
| 18 | Renaissance Technologies13 funds on PPLI.com | USD 3.6m | 0.0% |
| 19 | Exoduspoint Capital Management7 funds on PPLI.com | USD 3.4m | 0.0% |
| 20 | Verition Fund Management3 funds on PPLI.com | USD 3m | 0.0% |
| 21 | Aquatic Capital Management3 funds on PPLI.com | USD 2.2m | 0.1% |
| 22 | Balyasny Asset Management25 funds on PPLI.com | USD 2.1m | 0.0% |
| 23 | Cinctive Capital Management5 funds on PPLI.com | USD 1.9m | 0.1% |
| 24 | Iconiq Capital13 funds on PPLI.com | USD 1.8m | 0.1% |
| 25 | Squarepoint Ops7 funds on PPLI.com | USD 1.7m | 0.0% |
| 26 | Persistent Asset Partners10 funds on PPLI.com | USD 1.3m | 0.4% |
| 27 | J. Goldman & Co.1 fund on PPLI.com | USD 1.1m | 0.0% |
| 28 | Exome Asset Management2 funds on PPLI.com | USD 889,000 | 0.5% |
| 29 | Brandywine Managers47 funds on PPLI.com | USD 719,000 | 0.4% |
| 30 | Marshall Wace LLP84 funds on PPLI.com | USD 334,000 | 0.0% |
| 31 | The Quarry1 fund on PPLI.com | USD 1,347 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Casdin Capital | USD 300m | 15.0% |
| 2 | Perceptive Advisors | USD 264m | 4.0% |
| 3 | Kynam Capital Management | USD 62m | 3.4% |
| 4 | HighVista Strategies | USD 9.5m | 2.2% |
| 5 | ECOR1 Capital | USD 13m | 0.6% |
| 6 | Boxer Capital Management | USD 8.4m | 0.6% |
| 7 | Sphera Funds Management | USD 4.4m | 0.6% |
| 8 | Exome Asset Management | USD 889,000 | 0.5% |
| 9 | Arrowmark Colorado Holdings | USD 10m | 0.4% |
| 10 | Eversept Partners | USD 8.1m | 0.4% |
Relay Therapeutics, Inc. trades under the symbol RLAY on the Nasdaq. Its CUSIP, the code used on Form 13F, is 75943R102.
31 of the 720 hedge fund managers PPLI.com tracks reported Relay Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Casdin Capital (USD 300m), Perceptive Advisors (USD 264m), Kynam Capital Management (USD 62m), Baker Bros. Advisors (USD 53m) and Polar Capital LLP (USD 33m).
31 managers in our coverage reported it, and between them they run 400 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Casdin Capital, where the position was 15.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Relay Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.